Treatment was shown to result in a significant reduction in CD8 T cell infiltration into tumours, but not CD4 T cell or γδ T cell infiltration, which corresponds with our earlier observation of the key role played by CD8 T cells in SCC rejection. Here, CD8A is linked to neoplasm.